Skip to Content
PharmaceuticalsPharmaceuticals
  • Correction
  • Open Access

29 July 2025

1 Page

Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302

,
,
,
,
,
and
1
Operative Unit of Pharmacology and Pharmacovigilance, “Renato Dulbecco” University Hospital, 88100 Catanzaro, Italy
2
Research Center FAS@UMG, Department of Health Science, University Magna Graecia, 88100 Catanzaro, Italy
*
Author to whom correspondence should be addressed.

Text Correction

In the original publication [1], there was an error in the Discussion section. The sentence originally stated:
“In our study, we excluded patients with a Body Mass Index lower than 29 kg/m2…”
This has been corrected to:
“In our study, we enclosed only patients with a Body Mass Index lower than 29 kg/m2…”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has been updated accordingly.

Reference

  1. Rania, V.; Marcianò, G.; Vocca, C.; Palleria, C.; Bianco, L.; Caroleo, M.C.; Gallelli, L. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.